TITLE

Endothelial Progenitor Cell Dysfunction in Polycystic Ovary Syndrome: Implications for The Genesis of Cardiovascular Diseases

AUTHOR(S)
Yu-Hsun Kao; Wan-Chun Chiu; Ming-I Hsu; Yi-Jen Chen
PUB. DATE
January 2013
SOURCE
International Journal of Fertility & Sterility;Winter2013, Vol. 6 Issue 4, p208
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Polycystic ovary syndrome (PCOS), the most common endocrine disorder affecting women of reproductive age, is characterized by hyperandrogenism and insulin resistance. Women with PCOS have a higher risk for cardiovascular diseases (CVDs) and endothelial dysfunction. The mechanisms underlying these risks are unclear. Human peripheral blood contains circulating endothelial progenitor cells (EPCs) derived from bone marrow that have the ability to proliferate and differentiate into mature endothelial cells, which may contribute to vessel homeostasis and repair. PCOS is associated with insulin resistance, hyperinsulinemia, and dyslipidemia, which may result in EPC dysfunction. In this review, we summarize the potential mechanisms of EPC dysfunction in PCOS, which possibly result in a higher genesis of CVDs in PCOS-affected subjects.
ACCESSION #
85926990

 

Related Articles

  • Polycystic Ovarian Syndrome: Metformin or Thiazolidinediones for Cardiovascular Risk Reduction? Janci, Mary Moyer; Smith, Rhea Coquia; Odegard, Peggy Soule // Diabetes Spectrum;Fall2012, Vol. 25 Issue 4, p229 

    The article discusses a study pertaining to the relationships among polycystic ovarian syndrome (PCOS), diabetes, and cardiovascular (CV) risk, reviewing the use of metformin and thiazolidinediones (TZDs) in reducing CV risk. The methods used are meta-analyses, clinical trials and controlled...

  • Insulin-like growth factor 1, liver enzymes, and insulin resistance in patients with PCOS and hirsutism. ÇAKIR, Evrim; TOPALOĞLU, Oya; BOZKURT, Nujen ÇOLAK; BAYRAKTAR, Başak KARBEK; GÜNGÜNES, Aşkin; ARSLAN, Müyesser SAYKI; ÜNSAL, İlknur ÖZTÜRK; TUTAL, Esra; UÇAN, Bekir; DELİBAŞI, Tuncay // Turkish Journal of Medical Sciences;2014, Vol. 44 Issue 5, p781 

    Aim: Hyperinsulinemia and insulin resistance are commonly seen in patients with hirsutism and polycystic ovary syndrome (PCOS), and are associated with cardiovascular disease risk. However, it is not yet known whether insulin-like growth factor I (IGF-I) and alanine transaminase (ALT) produced...

  • Insulin Resistance and Lipid Accumulation Product in Correlation to Body Mass Index in Women with Polycystic Ovary Syndrome. Godinjak, Amina; Godinjak, Zulfo; Burekovic, Azra; Surkovic, Ismana; Dizdarevic-Bostandzic, Amela; Velija-Asimi, Zelija // Medical Archives / Medicinski Arhiv;2012, Vol. 66 Issue 6, p409 

    Introduction: Women with Polycystic Ovary Syndrome (PCOS) are at increased risk for cardiovascular morbidity and metabolic disorders including: dyslipidaemia, hypertension, insulin resistance, gestational diabetes, type 2 diabetes, systemic inflammation and endothelial dysfunction. The...

  • COMPARATIVE STUDY ON CARDIOVASCULAR RISK FACTORS IN NEWLY DIAGNOSED PATIENTS WITH POLYCYSTIC OVARY SYNDROME (PCOS) AND PCOS PATIENTS WHO ARE ON DRUG METFORMIN. Farhan, Yasir M.; Taher, Mohammed A.; Alhadithy, Eman M. // International Journal of Science & Nature;2012, Vol. 3 Issue 1, p24 

    Case-control study was conducted to evaluate the effect of metformin on cardiovascular risk factors in women with polycystic ovary syndrome on three groups of women included: Thirty two patients newly diagnosed with PCOS without treatment, 30 patients with PCOS treated with metformin more than 4...

  • ANDROGEN EXCESS AS A MAJOR DETERMINANT OF CARDIOVASCULAR RISK IN WOMEN: EVIDENCE FROM THE POLYCYSTIC OVARY SYNDROME. Pepene, C. E. Georgescu // Acta Endocrinologica (1841-0987);Oct-Dec2011, Vol. 7 Issue 4, p529 

    Apart from endocrine and reproductive disturbances, polycystic ovary syndrome (PCOS) clusters several cardiovascular risk factors, mainly insulin resistance, obesity and dyslipidemia. In addition, androgen excess significantly contributes to enhanced vascular risk. Several mediators of...

  • Polycystic ovary syndrome: clinical implication in perimenopause. Lenart-Lipińska, Monika; Matyjaszek-Matuszek, Beata; Woźniakowska, Ewa; Solski, Janusz; Tarach, Jerzy S.; Paszkowski, Tomasz // Menopausal Review / Przeglad Menopauzalny;2014, Vol. 13 Issue 6, p348 

    Polycystic ovary syndrome (PCOS), a hyperandrogenic disorder, is the commonest endocrinopathy in premenopausal women. This syndrome is associated with fertility problems, clinical manifestations of hyperandrogenism and metabolic disturbances, particularly insulin resistance and obesity. There is...

  • Insulin Resistance and Polycystic Ovary Syndrome. Choudhary, Sunita; Rajnee; Binawara, Bijendra Kumar; Mathur, Kamlesh Chandra // Pakistan Journal of Medical Research;Apr2012, Vol. 51 Issue 2, p63 

    Polycystic ovarian syndrome is a heterogeneous disorder, characterized by cystic ovarian morphology, androgen excess and irregular periods that occurs during or shortly after the onset of puberty. Insulin resistance and consequent hyperinsulinemia during this disorder promotes an ongoing state...

  • Polycystic ovarian syndrome in patients with lipodystrophy: Report of 2 cases with review of literature. Pahuja, Isha; De, Prasanjit; Sharma, Neera; Kulshreshtha, Bindu // Indian Journal of Endocrinology & Metabolism;Nov/Dec2012, Vol. 16 Issue 6, p1022 

    Lipodystrophy is a clinical disorder characterized by maldistribution of body fat. Hyperinsulinemia, insulin resistance, and abnormalities of glucose homeostasis are commonly described among these patients. Hyperinsulinemia is also involved in the pathogenesis of polycystic ovarian syndrome, a...

  • Cardiovascular disease risk in young women with polycystic ovary syndrome. Guleria, A.; Syal, S.; Kapoor, A.; Tiwari, P.; Dabadhgao, P. // Indian Journal of Endocrinology & Metabolism;Dec2012 Supplement, Vol. 16, pS393 

    Introduction: Polycystic ovary syndrome (PCOS) is a common disorder in women of reproductive age group. Insulin resistance and the consequent hyperinsulinemia seem to be the central pathophysiological mechanism that links PCOS to its associated metabolic derangements. Women with PCOS exhibit a...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics